We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

electroCore Inc (ECOR) USD0.001

Sell:$11.05 Buy:$12.19 Change: $0.85 (6.97%)
Market closed |  Prices as at close on 2 December 2024 | Switch to live prices |
Sell:$11.05
Buy:$12.19
Change: $0.85 (6.97%)
Market closed |  Prices as at close on 2 December 2024 | Switch to live prices |
Sell:$11.05
Buy:$12.19
Change: $0.85 (6.97%)
Market closed |  Prices as at close on 2 December 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Company’s TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.

Contact details

Address:
200 FORGE WAY, SUITE 205
ROCKAWAY
07866
United States
Telephone:
+1 (973) 2900097
Website:
https://www.electrocore.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ECOR
ISIN:
US28531P2020
Market cap:
$79.97 million
Shares in issue:
6.55 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Daniel Goldberger
    Chief Executive Officer, Director
  • Joshua Lev
    Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.